glp 1 sales GLP-1 Receptor Agonist Market Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034 Waistlines and GLP-1s—Expanding in Unison
Description
However, many insurance companies do not cover weight loss medications such as Wegovy and Zepbound when used solely for weight reduction
Both medications are taken as once-weekly subcutaneous injections and work best alongside a reduced-calorie diet and regular physical activity
10.1111/j.1476-5381.2010.01107.x 42 GandasiN
20.Newsome PN, Buchholtz K, Cusi K, Linder M, Okanoue T, Ratziu V, et al
The FDA has warned patients to be cautious with unapproved GLP-1 products and notes that compounded drugs are not reviewed by the agency for safety, effectiveness, or quality before marketing
